Canada markets closed

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
42.47+0.40 (+0.95%)
At close: 04:00PM EDT
42.80 +0.33 (+0.78%)
After hours: 07:26PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 7.71B
Enterprise Value 7.09B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)11.45
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -17.04

Trading Information

Stock Price History

Beta (5Y Monthly) 1.49
52-Week Change 335.69%
S&P500 52-Week Change 322.36%
52 Week High 343.59
52 Week Low 319.59
50-Day Moving Average 341.87
200-Day Moving Average 332.87

Share Statistics

Avg Vol (3 month) 31.39M
Avg Vol (10 day) 3979.16k
Shares Outstanding 5181.58M
Implied Shares Outstanding 6181.58M
Float 877.23M
% Held by Insiders 115.32%
% Held by Institutions 186.08%
Shares Short (Apr 15, 2024) 47.92M
Short Ratio (Apr 15, 2024) 45.97
Short % of Float (Apr 15, 2024) 49.18%
Short % of Shares Outstanding (Apr 15, 2024) 44.36%
Shares Short (prior month Mar 15, 2024) 46.96M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-24.73%
Return on Equity (ttm)-72.44%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -441.64M
Net Income Avi to Common (ttm)-432.84M
Diluted EPS (ttm)-2.67
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)990.96M
Total Cash Per Share (mrq)5.46
Total Debt (mrq)480.78M
Total Debt/Equity (mrq)71.36%
Current Ratio (mrq)10.92
Book Value Per Share (mrq)3.71

Cash Flow Statement

Operating Cash Flow (ttm)-342.3M
Levered Free Cash Flow (ttm)-198.16M